Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 56, Issue 41, Pages 12548-12552Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201705609
Keywords
bioorthogonal; fluorescent probes; gold; heterogeneous catalysis; prodrugs
Categories
Funding
- EPSRC [EP/N021134/1]
- CRUK
- Royal Society [RG150377]
- EC (ChemoBOOM) [H2020-MSCA-IF-2014-658833]
- CMVM of the University of Edinburgh
- CIBER-BBN
- VI National RDi Plan
- Instituto de Salud Carlos III
- University of Zaragoza [JIUZ-2016-TEC-13]
- ERC under the EU's [340163]
- EPSRC [EP/N021134/1] Funding Source: UKRI
- Cancer Research UK [17494] Funding Source: researchfish
- Engineering and Physical Sciences Research Council [EP/N021134/1] Funding Source: researchfish
Ask authors/readers for more resources
Recent advances in bioorthogonal catalysis are increasing the capacity of researchers to manipulate the fate of molecules in complex biological systems. A bioorthogonal uncaging strategy is presented, which is triggered by heterogeneous gold catalysis and facilitates the activation of a structurally diverse range of therapeutics in cancer cell culture. Furthermore, this solid-supported catalytic system enabled locally controlled release of a fluorescent dye into the brain of a zebrafish for the first time, offering a novel way to modulate the activity of bioorthogonal reagents in the most fragile and complex organs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available